New Guidelines Recommend Shorter All-Oral TB Treatment Regimens
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Tag: ATS American Thoracic Society
All
Latest
New Guidelines Recommend Shorter All-Oral TB Treatment Regimens
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read More
ATS Offers Guidance for Hospitals on IV Fluid Shortages
New guidance provides hospitals with strategies to mitigate the impact of IV fluid shortages caused by recent hurricane-related disruptions in key manufacturing facilities.
Read More
World Oxygen Day Sparks Renewed Calls for Congressional Action on Supplemental Oxygen Access
Healthcare organizations are urging Congress to pass the SOAR Act to ensure Medicare patients have access to the supplemental oxygen they need for improved health and mobility.
Read More
Sleep Apnea Researcher Receives Lifetime Achievement Award
The recipient was lauded as “one of the most productive scholars in the world over the past several decades.”
Read More
ATS Announces New Leadership at Annual Conference
The American Thoracic Society announced its new leadership for 2024-2025 during the Plenary Session at the ATS 2024 International Conference.
Read More
ATS Welcomes New President
The American Thoracic Society appointed Irina Petrache, MD, ATSF, as its incoming president today at the ATS 2024 International Conference.
Read More
Former Smokers Who Vape at Greater Risk of Lung Cancer
Former cigarette smokers who use e-cigarettes or vaping devices may be at higher risk for lung cancer than those who don’t vape, according to research presented at ATS 2024.
Read More
Race-Neutral Spirometry Equations May Boost Black Patient Enrollment in COPD Trials
Eliminating racially adjusted spirometry results could lead to a significant increase in Black patient participation in COPD clinical trials, according to findings presented at ATS 2024.
Read More
ATS Kicks Off Annual Conference in San Diego
American Thoracic Society President M. Patricia Rivera, MD, ATSF, opened ATS 2024 in San Diego with a call to shape the future of respiratory health.
Read More
Asthma Education is Key to Reducing Deaths Worldwide
International healthcare groups are urging greater patient education on World Asthma Day 2024.
Read More
Eliminating Racial Bias in Spirometry/PFT Interpretation
Industry research has highlighted the potential of racial bias in the interpretation of spirometry and other PFT that can lead to delayed care (or lack of care) in Black patients.
Read More
ATS Announces 2024 Respiratory Health Award Recipients
Awardees will be formally recognized for their contributions to the field at the ATS 2024 International Conference.
Read More
Congress Introduces SOAR Act to Improve Supplemental Oxygen Access
The Supplemental Oxygen Access Reform Act of 2024, designed to ease access to supplemental oxygen for Medicare beneficiaries, was introduced in the US House of Representatives by a bipartisan group of members of Congress.
Read More
EPA Finalizes Stronger Air Pollution Standards
The EPA also issued new threshold levels for the Air Quality Index, changing the pollution levels needed to trigger some alerts.
Read More
World COPD Day 2023 Emphasizes Early Detection
On November 15th, healthcare organizations across the globe are observing World COPD Day 2023 by emphasizing the importance of early disease detection.
Read More
New Guidance for Treating Systemic Sclerosis-associated ILD
A new ATS clinical practice guideline recommends expanding antifibrotic treatment to all patients with systemic sclerosis associated with ILD, not just those with progressive disease.
Read More
Wildfires Impact Health Across Every US Region
ATS’s Health of the Air report provides local and national estimates of the health impacts of outdoor air pollution and, for the first time, estimates of the health impacts specifically attributable to air pollution from wildfires.
Read More
ATS Broadens Vaccine Push with Partnership from Five More Health Systems
The health systems will prioritize improving vaccine rates among high-risk adults with lung disease across different populations.
Read More
ATS and Lung Association ‘Disappointed’ by EPA’s Ozone Review Decision
The American Lung Association says EPA’s decision means the public will now have to “wait years” for a stronger national limit on ozone.
Read More
Pulmonary Rehabilitation Gets ‘Strong’ Recommendation in New ATS Guideline
The latest guideline from the American Thoracic Society reaffirms benefits for patients with COPD as well as pulmonary hypertension and interstitial lung disease.
Read More
Race-neutral Testing Key to Equal Lung Transplant Access
Researchers found that a race-specific approach to lung function testing resulted in a lower lung allocation score for Black patients and higher lung allocation score for White patients, which may have contributed to racially biased allocation of lung transplants.
Read More
PAP Therapies Linked to Lower Mortality and Enhanced Quality of Life
Medical experts at the American Thoracic Society International Conference unveiled new evidence that demonstrates the benefits of positive airway pressure therapies for patients with sleep apnea.
Read More
Digital Biomarker Predicts Risk of Death in Interstitial Lung Diseases
The tool, which has been granted FDA Breakthrough Device Designation, is being developed to serve as adjunct in assessment of ILD, potentially avoiding expensive, invasive surgical testing.
Read More
Mount Sinai Pulmonologists Present Asthma, Sleep Research at ATS 2023
World renowned pulmonologists from the Mount Sinai Health System in New York City have prepared research for the American Thoracic Society (ATS) 2023 International Conference in Washington, DC.
Read More